Long-Term Cardiorespiratory, Endocrine, Ophthalmic, and Functional Outcomes in Adult Patients with Mucopolysaccharidosis Type I (Hurler Syndrome) Post Haematopoietic Stem Cell Transplantation: The Irish Experience

Abstract Mucopolysaccharidosis type IH (MPS IH) is caused by homozygous IDUA gene pathogenic variants. This results in deficiency of the enzyme α-L-iduronidase (IDUA), which is necessary for the degradation of glycosaminoglycans (GAGs). This study outlines the long-term outcomes in adult Irish patie...

Full description

Bibliographic Details
Published in:	Journal of Inborn Errors of Metabolism and Screening
Main Authors:	Karolina M. Stepien, Max Treacy, Roulla Katiri, Eileen P. Treacy, Gregory Pastores, Alison Sheerin, Donal Brosnahan, Ellen Crushell, James J. O’Byrne
Format:	Article
Language:	English
Published:	SciELO 2024-07-01
Subjects:	Mucopolysaccharidosis type I MPS IH Hurler syndrome Haematopoietic stem cell transplantation long-term outcomes
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942024000100302&lng=en&tlng=en

Similar Items

Rare cases of mucopolysaccharidosis type I in children with Hurler and Hurler-Scheie syndromes
by: A. E. Babushkin, et al.
Published: (2018-10-01)

Differential Diagnosis of Hurler and Hurler–Scheie Syndromes: Clinical Case
by: Nataliya V. Buchinskaya, et al.
Published: (2025-05-01)

Mucopolysaccharidosis Type 1 among Children—Neuroradiological Perspective Based on Single Centre Experience and Literature Review
by: Magdalena Machnikowska-Sokołowska, et al.
Published: (2023-01-01)

Mucopolysaccharidosis Type I (Hurler – Scheie Syndrome): Case Report
by: Nato D. Vashakmadze, et al.
Published: (2024-09-01)

Open issues in Mucopolysaccharidosis type I-Hurler
by: Rossella Parini, et al.
Published: (2017-06-01)

Hurler–Scheie syndrome in Niger: a case series
by: Hamid Assadeck, et al.
Published: (2019-04-01)

Liver-directed gene therapy corrects neurologic disease in a murine model of mucopolysaccharidosis type I-Hurler
by: Xiu Jin, et al.
Published: (2022-06-01)

Combination Treatment for Severe Forms of Mucopolysaccharidosis, Type I (Hurler Syndrome): Case Report
by: Nato V. Vashakmadze, et al.
Published: (2023-12-01)

Anesthetic management in children with Hurler′s syndrome undergoing emergency ventriculoperitoneal shunt surgery
by: Nidhi Gupta, et al.
Published: (2012-01-01)

Successful treatment of corneal hypertrophic scar in Hurler syndrome
by: Nima Koosha, et al.
Published: (2024-07-01)

Clinical manifestation of Hurler syndrome in a 7 year old child
by: S Sharma, et al.
Published: (2012-01-01)

Predictors of growth patterns in children with mucopolysaccharidosis I after haematopoietic stem cell transplantation
by: Stefanie Maier, et al.
Published: (2022-07-01)

Orthopedic Pathology in Children with Mucopolysaccharidosis Type I
by: Nato D. Vashakmadze, et al.
Published: (2016-12-01)

Ocular features in mucopolysaccharidosis: diagnosis and treatment
by: Alessandra Del Longo, et al.
Published: (2018-11-01)

<i>Drosophila</i> D-idua Reduction Mimics Mucopolysaccharidosis Type I Disease-Related Phenotypes
by: Concetta De Filippis, et al.
Published: (2021-12-01)

Imaging hallmarks of mucopolysaccharidosis in a young Ethiopian boy: A case report
by: Muluken Yifru Gebresilassie, MD, et al.
Published: (2025-09-01)

CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis
by: Mehran Reyhani-Ardabili, et al.
Published: (2024-09-01)

An online survey on burden of illness among families with post-stem cell transplant mucopolysaccharidosis type I children in the United States
by: Therese Conner, et al.
Published: (2019-02-01)

Diagnostic Difficulties of Mucopolysaccharidosis Type I Mild Forms: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2020-06-01)

Haematopoietic stem cell gene therapy with IL‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA
by: Helen Parker, et al.
Published: (2020-02-01)

Ameloblastoma in a Three-Year-Old Child with Hurler Syndrome (Mucopolysaccharidosis Type I)
by: Mattia Di Bartolomeo, et al.
Published: (2022-03-01)

Delayed diagnosis of mild mucopolysaccharidosis type IVA
by: Mengni Yi, et al.
Published: (2024-06-01)

Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I
by: Daniel A. Wolf, et al.
Published: (2011-07-01)

Ventriculoperitoneal shunt and bilateral herniotomies in mucopolysaccharidosis type I: A surgical challenge
by: Rahul Gupta, et al.
Published: (2024-08-01)

Evaluation of Multiple Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I
by: Zackary M. Herbst, et al.
Published: (2020-08-01)

Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation Results in Patients with Hurler Syndrome: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2019-09-01)

α-mannosidosis diagnosis in Brazilian patients with MPS-like symptoms
by: Maryana Marins, et al.
Published: (2024-11-01)

Mucopolysaccharidosis type I Hurler-Scheie syndrome: A rare case report
by: Ramesh Tatapudi, et al.
Published: (2011-01-01)

Initiation of fluoxetine in a pediatric patient with Mucopolysaccharidosis IIIA: Early observations
by: Lindsay Torrice, et al.
Published: (2024-09-01)

Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru
by: Tatiana Pineda, et al.
Published: (2014-01-01)

Mucopolisacaridosis (síndrome de Hunter)
by: Xidix Toirac Cabrera, et al.

Trigger finger in children with hurler syndrome – distribution pattern and treatment options
by: Jokuszies, Andreas, et al.
Published: (2021-05-01)

Hip pathologies in mucopolysaccharidosis type III
by: Sandra Rafaela Breyer, et al.
Published: (2021-03-01)

Prioritisation of head, neck, and respiratory outcomes in mucopolysaccharidosis type II: lessons from a rare disease consensus exercise and comparison of parental and clinical priorities
by: James Dempsey, et al.
Published: (2025-02-01)

Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement
by: Christiane S. Hampe, et al.
Published: (2021-01-01)

Articular Syndrome Characteristics in Children with Mucopolysaccharidosis Type I
by: Nato D. Vashakmadze, et al.
Published: (2021-12-01)

Mucopolysaccharidosis Type IIIE: A Real Human Disease or a Diagnostic Pitfall?
by: Karolina Wiśniewska, et al.
Published: (2024-08-01)

Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: A case report
by: Erlane Marques Ribeiro, et al.
Published: (2014-01-01)

Parental perception of treatment options for mucopolysaccharidosis: a survey to bridge the gap for personalized medicine
by: Anna-Maria Wiesinger, et al.
Published: (2025-01-01)

How Not to Miss the Mild Forms of Mucopolysaccharidosis Type I in Patients With Articular Manifestations of the Disease?
by: Natalia V. Buchinskaya, et al.
Published: (2019-01-01)